{
    "2020-12-06": [
        [
            {
                "time": "",
                "original_text": "【中金医药】关注B类股流动性提升机会；静待医保谈判落地 - 中金医药周报系列八十一",
                "features": {
                    "keywords": [
                        "B类股",
                        "流动性提升",
                        "医保谈判",
                        "中金医药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2021年医药生物行业策略报告：聚焦黄金赛道 寻找疫后高光",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业策略",
                        "黄金赛道",
                        "疫后高光"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}